Antares Vision — Net Asset Value 2022

Apr 20, 2022

PRESS RELEASE

PROCEDURES AND EXERCISE RATIO OF ANTARES VISION WARRANTS

Travagliato (BS), 20 April 2022 - Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation" 1 and the "Warrants"), the Average Monthly Price for March 2022 is Euro 8.5857 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in March).

Therefore, since the Average Monthly Price for March 2022, equal to Euro 8.5857, is lower than the Strike Price, equal to 9.50 euros, the warrants cannot be exercised during the month of April 2022.

We remind that, in accordance with the Company's financial calendar previously disclosed to the public on 18 January 2022 and in view of the Company's Annual General Meeting of Shareholders scheduled, with a single date, for April 22, 2022, the Exercise Period, pursuant to Article 3.12 of the Warrant Regulations is automatically suspended until 22 April 2022, included.

Antares Vision also announces that in March, no exercise requests were received. Consequently, the share capital of Antares Vision (Euro 169,452.91, divided into 69,119,526 ordinary shares, 250,000 Special Shares and 1,189,590 Performance Shares, with no nominal value indicated for any category) remained unchanged as well as the warrants outstanding (equal to 2,490,400).

For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvision.com - "Investors – Investor Relations – Warrant" section.

ABOUT ANTARES VISION GROUP

Antares Vision Group is an outstanding technology partner in digitalization and innovation for enterprises and institutions, guaranteeing the safety of products and people, business competitiveness and environmental protection.

Antares Vision Group is a technological enabler of supply chain transparency and of sustainable transition, to protect business competitiveness and the uniqueness of each country.

It provides a unique and comprehensive ecosystem of technologies to guarantee product quality (inspection systems and equipment) and end-to-end product traceability (from raw materials to production, from distribution to the consumer), with integrated data, production and supply chain management, also achieved through the application of artificial intelligence and the use of blockchains.

Antares Vision Group is active in the Life Science sector (pharmaceutical, biomedical devices and hospitals), in the beverage, food and cosmetics industries, and has potential in other sectors. The world leader in Track&Trace systems for pharmaceutical products, it provides the major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities with solutions to monitor their supply chains and validate product authenticity.

Listed since April 2019 on the Italian Stock Exchange in the AIM (Alternative Investment Market) segment, and from 14 May 2021 in the STAR segment of the MTA (Electronic equity market), Antares Vision Group recorded a turnover of Euro 162 million in 2020, operates in 60 countries, employs around 1000 people and has a consolidated network of over 40 international Partners.

¹ The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.

PRESS RELEASE

Further information please visit www.antaresvision.com and www.antaresvisiongroup.com

For further information

ISSUER ANTARES VISION GROUP ALESSANDRO BAJ BADINO (HEAD OF INVESTOR RELATIONS) TEL.: +39 030 72 83 500 E-MAIL: INVESTORS@ANTARESVISION.COM